SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-057718
Filing Date
2017-11-09
Accepted
2017-11-09 16:06:05
Documents
6
Period of Report
2017-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv479085_8k.htm 8-K 16873
2 EXHIBIT 99.1 tv479085_ex99-1.htm EX-99.1 102382
3 GRAPHIC image_003.jpg GRAPHIC 3363
4 GRAPHIC image_001.jpg GRAPHIC 5911
5 GRAPHIC image_001.gif GRAPHIC 43
6 GRAPHIC image_002.gif GRAPHIC 42
  Complete submission text file 0001144204-17-057718.txt   133954
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 171190794
SIC: 2834 Pharmaceutical Preparations